The trial to set a suitable period of using esomeprazole and polaprezinc to cure the gastric ulcer after endoscopic submucosal resection (ESD) for mucosal cancers of the stomach.

The trial to set a suitable period of using esomeprazole and polaprezinc to cure the gastric ulcer after endoscopic submucosal resection (ESD) for mucosal cancers of the stomach. - The trial to set a suitable period of using esomeprazole and polaprezinc to cure the gastric ulcer after endoscopic submucosal resection (ESD) for mucosal cancers of the stomach.

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000010924

Enrollment

Registered

2013-06-11

Start date

2013-06-11

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

mucosal cancer of the stomach

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients who were resected the mucosal cancer of the stomack by endoscopic submucosal resection (ESD).

Exclusion criteria

Exclusion criteria: 1)Hyper sensitivity of Esomeprazole 2)Hyper sensitivity of Polaprezinc 3)Taking the medicine which is prohibited to take together with Esomeprazole or Polaprezinc 4)Under pregnancy or brest-feeding 5)Impossibility of oral intake 6)Past history of resection of upper GI 7)Taking medecines which are possible to interact with Esomeprazole or Polaprezinc

Design outcomes

Primary

Measure	Time frame
A period to cure the ESD ulcer in the stomach.	—

Secondary

Measure	Time frame
A period required to cure the ESD ulcer relative to its location and size, respectively. A rate of the ulcer healing at the time of 4 weeks, 6 weeks, and 8 weeks after ESD, respectively. A rate of the ulcer shrinkage at the time of 4 weeks, 6 weeks, and 8 weeks after ESD, respectively.	—

Countries

Japan

Contacts

Public ContactEri Uchida

Machida municipal hospital Department of Gastroenterology

eri_uchida0713@yahoo.co.jp042-722-2230

Outcome results